Peer-reviewedCC BY 4.0Metabolomics
Host metabolic responses to SARS-CoV-2 and influenza viruses: parallels and contrasts
Related
- Self-amplifying RNA vaccines encoding chimeric and mosaic hemagglutinins confer immunity against phylogenetically diverse influenza A viruses
- Antibody 3CF5 neutralizes historical and emerging H5Nx influenza viruses by targeting a conserved non-receptor-binding hemagglutinin epitope
- Targeted Engineering of Human MxA Yields a Broad-Spectrum Super-Restrictor of Human-Adapted Influenza Viruses
- Highly Pathogenic Avian Influenza Viruses H5N1 and H5N5 in Red Foxes (Vulpes vulpes) in Norway during 2022-2024
- N1 neuraminidase monoclonal antibodies 2H08 and 3H03 have decreased binding and inhibition properties against H1N1 influenza viruses circulating after 2018
BibTeX
@article{terra2026host,
title = {{Host metabolic responses to SARS-CoV-2 and influenza viruses: parallels and contrasts}},
author = {Charles Terra and Olivier Terrier and Audrey Le Gouellec},
journal = {Metabolomics},
year = {2026},
month = jun,
doi = {10.1007/s11306-026-02454-0},
url = {https://hal.science/hal-05775353v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Host metabolic responses to SARS-CoV-2 and influenza viruses: parallels and contrasts
AU - Charles Terra
AU - Olivier Terrier
AU - Audrey Le Gouellec
PY - 2026
DA - 2026/06/02
JO - Metabolomics
DO - 10.1007/s11306-026-02454-0
UR - https://hal.science/hal-05775353v1
SN - 1573-3882
SN - 1573-3890
ER -